Neuronetics, Inc. cotiza a 2.13 USD y tiene una capitalización bursátil de $162M. En los últimos 12 meses ha facturado $155M con un margen de flujo de caja libre del -14.2%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroSt…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | — | $-0.15 | $-0.10 |
| Estimado | $-0.11 | $-0.12 | $-0.17 | $-0.11 |
| Sorpresa | — | — | +11.8% | +9.1% |
| Métrica | STIM | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 48.5% | 57.0% | -8.6% |
| Operating Margin | -21.1% | -38.6% | +17.5% |
| Net Margin | -26.1% | -33.6% | +7.4% |
| FCF Margin | -14.2% | -13.9% | -0.3% |
| ROE | -174.3% | -40.4% | -133.9% |
| ROA | -27.6% | -32.0% | +4.5% |
| Current Ratio | 2.02 | 2.84 | -0.82 |
| Debt / Equity | 2.94 | 0.28 | +2.66 |